大麻和类风湿关节炎:一个范围审查评估益处,风险和未来研究方向
Nicole Paland1, Haya Hamza1, Antonina Pechkovsky1
1Medical Cannabis Research and Innovation Center, Rambam Health Care Campus, Haifa, Israel.
Rambam Maimonides medical journal
|November 2, 2023
概括
大麻因其抗炎和缓解疼痛的特性而显示出对类风湿性疾病的潜力. 然而,需要更多的临床研究来确定其在治疗诸如类风湿性关节炎等疾病方面的疗效和安全性.
科学领域:
- 类风湿病学 类风湿病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 类风湿性疾病会导致渐进的关节炎症,疼痛和损伤,降低生活质量.
- 目前针对类风湿性疾病的治疗方法在疾病修饰和疼痛管理方面有效性有限.
- 对于类风湿性疾病,迫切需要新的治疗策略.
研究的目的:
- 审查大麻素作为治疗类风湿性疾病的潜力.
- 在临床前和临床研究中探索大麻素的抗炎和止痛特性.
- 评估大麻用于治疗类风湿性疾病的疗效和安全性.
主要方法:
- 对临床前研究,临床试验和回顾性分析的文献综述.
- 对大麻和大麻类药物用于类风湿性关节炎,骨关节炎和纤维肌痛的使用数据的检查.
- 分析报告的抗炎和止痛作用和不良事件.
主要成果:
- 临床前研究表明,大麻素可以减少类风湿性疾病模型中的炎症和疼痛.
- 关于大麻治疗类风湿性疾病的临床数据有限,结果不一.
- 大麻使用的不良影响需要仔细考虑.
结论:
- 大麻素显示出对类风湿性疾病的治疗潜力,需要进一步研究.
- 需要高质量的临床试验来证实大麻治疗的有效性和安全性.
- 目前的证据还不足以为使用大麻治疗类风湿性疾病制定临床指南.
相关概念视频
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
133
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
133
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
170
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
170


